Pitfalls of using the risk ratio in meta-analysis

被引:43
|
作者
Bakbergenuly, Ilyas [1 ]
Hoaglin, David C. [2 ]
Kulinskaya, Elena [1 ]
机构
[1] Univ East Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
关键词
beta-binomial model; log-binomial model; relative risk; response ratio; risk difference; BINARY OUTCOMES METHODS; RELATIVE RISK; CLINICAL-TRIALS; ABSOLUTE RISK; BINOMIAL MODEL; HETEROGENEITY; VARIANCE; BIAS; DIFFERENCE; REGRESSION;
D O I
10.1002/jrsm.1347
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
For meta-analysis of studies that report outcomes as binomial proportions, the most popular measure of effect is the odds ratio (OR), usually analyzed as log(OR). Many meta-analyses use the risk ratio (RR) and its logarithm because of its simpler interpretation. Although log(OR) and log(RR) are both unbounded, use of log(RR) must ensure that estimates are compatible with study-level event rates in the interval (0, 1). These complications pose a particular challenge for random-effects models, both in applications and in generating data for simulations. As background, we review the conventional random-effects model and then binomial generalized linear mixed models (GLMMs) with the logit link function, which do not have these complications. We then focus on log-binomial models and explore implications of using them; theoretical calculations and simulation show evidence of biases. The main competitors to the binomial GLMMs use the beta-binomial (BB) distribution, either in BB regression or by maximizing a BB likelihood; a simulation produces mixed results. Two examples and an examination of Cochrane meta-analyses that used RR suggest bias in the results from the conventional inverse-variance-weighted approach. Finally, we comment on other measures of effect that have range restrictions, including risk difference, and outline further research.
引用
收藏
页码:398 / 419
页数:22
相关论文
共 50 条
  • [41] Epilepsy and fracture risk: a meta-analysis
    Zhao, Dongming
    Cheng, Peng
    Zhu, Bo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 564 - U4845
  • [42] The Protein-to-Creatinine Ratio for the Prediction of Significant Proteinuria in Patients at Risk for Preeclampsia: a Meta-Analysis
    Sanchez-Ramos, Luis
    Gillen, Geoffrey
    Zamora, Javier
    Stenyakina, Anastasia
    Kaunitz, Andrew M.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2013, 43 (02): : 211 - 220
  • [43] Waist-hip ratio as a predictor of myocardial infarction risk: A systematic review and meta-analysis
    Cao, Qinqin
    Yu, Shui
    Xiong, Wenji
    Li, Yuewei
    Li, Huimin
    Li, Jinwei
    Li, Feng
    MEDICINE, 2018, 97 (30)
  • [44] Smoking and risk of glioma: a meta-analysis
    Lori Mandelzweig
    Ilya Novikov
    Siegal Sadetzki
    Cancer Causes & Control, 2009, 20 : 1927 - 1938
  • [45] Prediabetes and the risk of cancer: a meta-analysis
    Huang, Yi
    Cai, Xiaoyan
    Qiu, Miaozhen
    Chen, Peisong
    Tang, Hongfeng
    Hu, Yunzhao
    Huang, Yuli
    DIABETOLOGIA, 2014, 57 (11) : 2261 - 2269
  • [46] Waist-to-height ratio as a risk marker for metabolic syndrome in childhood. A meta-analysis
    Ochoa Sangrador, C.
    Ochoa-Brezmes, J.
    PEDIATRIC OBESITY, 2018, 13 (07): : 421 - 432
  • [47] Hypertension and Risk of Cataract: A Meta-Analysis
    Yu, Xiaoning
    Lyu, Danni
    Dong, Xinran
    He, Jiliang
    Yao, Ke
    PLOS ONE, 2014, 9 (12):
  • [48] Allergy and risk of glioma: a meta-analysis
    Chen, C.
    Xu, T.
    Chen, J.
    Zhou, J.
    Yan, Y.
    Lu, Y.
    Wu, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (03) : 387 - 395
  • [49] Meta-analysis methods for risk differences
    Bonett, Douglas G.
    Price, Robert M.
    BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY, 2014, 67 (03): : 371 - 387
  • [50] Statins and cancer risk - A meta-analysis
    Dale, KM
    Coleman, CI
    Henyan, NN
    Kluger, J
    White, CM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01): : 74 - 80